This section is designed for patients who are interested in participating in the REGAIN trial.
A drug is in development that may be able to restore hearing loss. The REGAIN study aims to test how safe the drug is and if it affects the ability to hear.
Recruitment for the trial isn't open yet, but we expect it to begin in the second half of 2017. If you'd like us to contact you with more information when the study is open to recruitment, please complete your details in the form on your right.